ThermoGenesis Holdings, Inc. (THMO) Financials

THMO Assets vs Liabilities

DateAssetsLiabilities
March 31, 2024 10.1 million 11.2 million
Dec. 31, 2023 11.2 million 14.8 million
Sept. 30, 2023 15.9 million 12.7 million
June 30, 2023 17.6 million 15.0 million

THMO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -525000 10000
Dec. 31, 2023 -2.2 million 9000
Sept. 30, 2023 -431000 7000
June 30, 2023 -1.4 million 13000

THMO Net Income

No data available :(

THMO Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 1.2 million 2.7 million 2.7 million
Dec. 31, 2023 2.0 million 5.8 million 2.9 million
Sept. 30, 2023 4.0 million 3.1 million 3.1 million
June 30, 2023 4.5 million 3.2 million 3.2 million

THMO Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 4.0 million
Dec. 31, 2023 3.6 million
Sept. 30, 2023 2.5 million
June 30, 2023 2.5 million

THMO Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 20000 211000 1.5 million -
Dec. 31, 2023 192000 329000 1.9 million -
Sept. 30, 2023 180000 266000 1.7 million -
June 30, 2023 590000 383000 1.8 million -

THMO Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 2.7 million 1.5 million
Dec. 31, 2023 2.4 million 2.4 million
Sept. 30, 2023 2.2 million 1.8 million
June 30, 2023 2.3 million 1.8 million

THMO Revenue by Segment

Graph available only for paid members. Upgrade to see it.

THMO

Price: $0

52 week price:
0.00
0.00

Earnings Per Share: -3.98 USD

Exchange: OEM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 63400

Market Capitalization: 1585

Links: